Bayer Kogenate FS
Bayer HealthCare, Biological Products Division

Contact Search Press Sitemap  
HomePatients & CaregiversHealthcare ProfessionalsPrescribing Information
Kogenate FS
Efficacy/Safety
BIO-SET
Patient Stories
Prescribing Information
Important Safety Information
Patient Video
EZ-Log
Bayer Factor Solutions
Kogenate Connections
Summer Camps
Hemophilia Awards
PEP
Rep Finder
Living with Hemophilia
Bayer Links
Bayer Global
Living with Hemophilia
   General Conditions of Use
Privacy Statement
Imprint
  
 
  

Simplicity

If you use 250, 500, or 1,000 IU vials of Kogenate FS, these vial sizes are reconstituted with 2.5 mL of sterile water. The 2000 IU vial size of Kogenate FS is reconstituted with 5 mL of sterile water. That's one quarter of the diluent volume required by some rFVIII products.

Convenient:

  • For administering to babies and children

  • For those with busy, active lifestyles

  • For those who treat bleeds frequently

  • For children learning to self-infuse

  • For larger patients with high-IU dosage, which fits in one syringe

Bayer HealthCare also makes available EZ-Log an electronic patient diary that simplifies

  • recording and tracking your Kogenate® FS hemophilia treatment information.

  • transmitting your treatment information to your healthcare provider.

  • receiving messages from your clinic.



 
  

Kogenate® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A. The most frequently reported adverse events were local injection site reactions, dizziness, and rash. Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Kogenate® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Kogenate® FS. For important safety and use information, please see the full prescribing information.

Please consult your health care provider prior to making any lifestyle changes. The images used on this site do not necessarily represent actual Hemophilia patients.